Human SPAG9(C-Jun-amino-terminal kinase-interacting protein 4) ELISA Kit
EH1393
Catalogue No.
- SPAG9 ELISA Kit, JIP-4 ELISA Kit, JNK-interacting protein 4 ELISA Kit, C-Jun-amino-terminal kinase-interacting protein 4 ELISA Kit, Protein highly expressed in testis ELISA Kit, PHET ELISA Kit, ProlifeRation-inducing protein 6 ELISA Kit, Mitogen-activated protein kinase 8-interacting protein 4 ELISA Kit, JNK-associated leucine-zipper protein ELISA Kit, JLP ELISA Kit, Sperm-specific protein ELISA Kit, Sperm-associated antigen 9 ELISA Kit, Human lung cancer oncogene 6 protein ELISA Kit, HLC-6 ELISA Kit
- Reactivity:
- Human
- Range:
- 0.156-10ng/ml
- Sensitivity:
- 0.094ng/ml
- Product Name
- Human SPAG9(C-Jun-amino-terminal kinase-interacting protein 4) ELISA Kit
- Catalogue No.
- EH1393
- Alias
- SPAG9 ELISA Kit, JIP-4 ELISA Kit, JNK-interacting protein 4 ELISA Kit, C-Jun-amino-terminal kinase-interacting protein 4 ELISA Kit, Protein highly expressed in testis ELISA Kit, PHET ELISA Kit, ProlifeRation-inducing protein 6 ELISA Kit, Mitogen-activated protein kinase 8-interacting protein 4 ELISA Kit, JNK-associated leucine-zipper protein ELISA Kit, JLP ELISA Kit, Sperm-specific protein ELISA Kit, Sperm-associated antigen 9 ELISA Kit, Human lung cancer oncogene 6 protein ELISA Kit, HLC-6 ELISA Kit
- Detection Method
- Sandwich ELISA, Double Antibody
- Application
- SPAG9 ELISA Kit allows for the in vitro quantitative determination of SPAG9 concentrations in serum, plasma, tissue homogenates and other biological fluids.
- Size
- 96T
- Range
- 0.156-10ng/ml
- Sensitivity
- < 0.094ng/ml
- Species
- Human
- UniProt ID
- O60271
- Standard curve
- Storage
- 2-8 ℃ for 6 months
- Recovery
Matrices listed below were spiked with certain level of SPAG9 and the recovery rates were calculated by comparing the measured value to the expected amount of SPAG9 in samples.
Matrix Recovery range(%) Average(%) serum(n=5) 85-101 93 EDTA plasma(n=5) 91-105 97 heparin plasma(n=5) 87-102 94 - Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of SPAG9 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample 1:2 1:4 1:8 serum(n=5) 91-101% 89-105% 85-104% EDTA plasma(n=5) 82-100% 89-101% 82-88% heparin plasma(n=5) 81-97% 81-91% 82-98% - CV(%)
- Intra-Assay: CV<8%
Inter-Assay: CV<10% - Note
- For Research Use Only